David Copolov

Jumping off the bandwagon: Does the Basaglian de-hospitalised model work outside Trieste?

Stephen Allison, Tarun Bastiampillai, Jeffrey CL Looi, David Copolov, Giuseppe Guaiana, Fiona Judd

Journal article  |  2020  |  AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Australia's National Mental Health Service Planning Framework: Are opinion-based algorithms driving mental health policy?

Stephen Allison, Tarun Bastiampillai, Jeffrey CL Looi, David Copolov

Journal article  |  2020  |  AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia

Nicholas Keks, Judith Hope, Darren Schwartz, Harold McLennan, David Copolov, Graham Meadows

Journal article  |  2020  |  CNS DRUGS

Aripiprazole, brexpiprazole and cariprazine differ from all other second-generation antipsychotics due to partial agonism at the d..

Pareto's law of the vital few: Patient requirements for hospital based non-acute care

Stephen Allison, Tarun Bastiampillai, Jeffrey CL Looi, David Copolov

Journal article  |  2019  |  AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Psychiatric bed numbers in Australia

Stephen Allison, Tarun Bastiampillai, David Copolov, David Castle

Journal article  |  2019  |  LANCET PSYCHIATRY

Have we overlooked the significance of multinodal hallucinations in schizophrenia?

Wei Lin Toh, Simon McCarthy-Jones, David Copolov, Susan L Rossell

Journal article  |  2019  |  PSYCHIATRY RESEARCH

Scant research attention has been devoted to the phenomenon of multimodal hallucinations, with majority of studies focusing on aud..

The challenges facing the public mental health sector: implications of the Victorian Psychiatry workforce project

Richard Newton, Adele Beasley, Peter Bosanac, David Castle, David Copolov, Mal Hopwood, Nick Keks, Nick Paoletti, John Tiller

Journal article  |  2019  |  AUSTRALASIAN PSYCHIATRY

OBJECTIVES: This paper reviews the major findings of the Victorian Psychiatry Attraction, Recruitment and Retention Needs Analysis..

Milnacipran: serotonin-noradrenaline reuptake inhibitor approved for fibromyalgia may be a useful antidepressant

Nicholas A Keks, Judy Hope, Simone Keogh, David L Copolov

Journal article  |  2018  |  AUSTRALASIAN PSYCHIATRY

OBJECTIVE: Milnacipran is a serotonin noradrenaline reuptake inhibitor (SNRI) approved for treatment of fibromyalgia in Australia,..

Targeting Zero: Implications for public psychiatric services

J Richard Newton, Peter Bosanac, David Copolov, Malcolm Hopwood, Nick Keks, Nick Paoletti, John Tiller, David Castle

Journal article  |  2017  |  AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Acceptance and commitment therapy for psychosis: randomised controlled trial

Frances Shawyer, John Farhall, Neil Thomas, Steven C Hayes, Robert Gallop, David Copolov, David J Castle

Journal article  |  2017  |  BRITISH JOURNAL OF PSYCHIATRY

BACKGROUND: The efficacy of acceptance and commitment therapy (ACT) in psychosis has been reported but not for medication-resistan..